Akari Therapeutics (AKTX) Prepaid Assets (2014 - 2026)
Akari Therapeutics' (AKTX) quarterly Prepaid Assets came in at $731000.0 in Q1 2026, up 813.75% year-on-year from $80000.0 in Q1 2025, and up 5121.43% quarter-over-quarter from $14000.0 in Q4 2025.
Akari Therapeutics (AKTX) Prepaid Assets (2014 - 2026) Analysis & Trends
Akari Therapeutics has disclosed Prepaid Assets across 13 years of filings, most recently posting $731000.0 for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $731000.0, up 813.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $731000.0 (up 813.75% YoY), and the FY2025 annual result was $14000.0, down 84.78% from the prior year.
- Prepaid Assets came in at $731000.0 for Q1 2026 at Akari Therapeutics, up from $14000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $805000.0 in Q2 2024 to a low of $14000.0 in Q4 2025.
- The 5-year median for Prepaid Assets is $197000.0 (2023), against an average of $286181.8.
- Across the five-year window, Prepaid Assets tumbled 89.69% in 2025 and surged 813.75% in 2026, its largest moves.
- Akari Therapeutics' Prepaid Assets stood at $465000.0 in 2022, then slumped by 57.63% to $197000.0 in 2023, then slumped by 53.3% to $92000.0 in 2024, then plunged by 84.78% to $14000.0 in 2025, then surged by 5121.43% to $731000.0 in 2026.
- The last three Prepaid Assets figures came in at $731000.0 (Q1 2026), $14000.0 (Q4 2025), and $53000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 731,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 396,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Mar 31, 2024 | 232,000.00 |
| Dec 31, 2023 | 197,000.00 |
| Dec 31, 2022 | 465,000.00 |
| Dec 31, 2021 | 2.17 Mn |
| Dec 31, 2020 | 292,680.00 |
| Sep 30, 2020 | 1.35 Mn |
| Jun 30, 2020 | 1.68 Mn |
| Mar 31, 2020 | 1.83 Mn |
| Dec 31, 2019 | 712,975.00 |
| Sep 30, 2019 | 1.06 Mn |
| Jun 30, 2019 | 1.75 Mn |
| Mar 31, 2019 | 1.89 Mn |